Moreover, GSEA analysis indicated that high PARP10 expression was involved in MYC, NFKB, and EZH2 target gene sets in AML patients, providing a potential and interesting direction for further exploration of its biological functions. The gene discussed is NFKB1; the disease is acute myeloid leukemia.